Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» Innovation Pharmaceuticals
Innovation Pharmaceuticals
Innovation Provides Update on Ph II Trial of Brilacidin for Severe Oral Mucositis in Head and Neck Cancer
Innovation Provides Update on Ph II Trial of Brilacidin for Severe Oral Mucositis in Head and Neck Cancer
CP Wire
Innovation Pharmaceuticals
Brilacidin-OM
clinical trials
oral mucositis
Flag link:
Innovation Provides Update on Ph II Trial of Brilacidin for Severe Oral Mucositis in Head and Neck Cancer
Innovation Pharmaceuticals
Brilacidin
oral mucositis
severe oral mucositis
Flag link:
More Promising Data from Innovation Pharmaceutical's Phase 2 Brilacidin Oral Mucositis Study
More Promising Data from Innovation Pharmaceutical's Phase 2 Brilacidin Oral Mucositis Study
CP Wire
Innovation Pharmaceuticals
severe oral mucositis
Brilacidin
Flag link:
More Promising Data from Innovation Pharmaceutical's Phase 2 Brilacidin Oral Mucositis Study
Innovation Pharmaceuticals
Flag link:
Innovation Pharmaceuticals Reports on Successful Phase II Trial of Brilacidin-OM for Oral Mucositis
Innovation Pharmaceuticals Reports on Successful Phase II Trial of Brilacidin-OM for Oral Mucositis
CP Wire
Innovation Pharmaceuticals
Brilacidin-OM
head and neck cancer
severe oral mucositis
Flag link:
